I think this piece of information about 4500 patient registered borders on material.
It gives an indication of the work already done by Acadia to prepare for the rollout.
With 8000-10000 known cases in the USA it’s now reasonable to expect registrations closer to 6000-8000 within the next 12-18 months
I think someone posted that Jon mentioned we need 2600 patients to clip the $1b revenue figures.
Even doubling that rounds that off to $2b
In regards to timelines it doesn’t bother me if it takes 2 years to get to that point and if the uptake is a bit slow for the first 2-3 quarters whilst they sort the prescription and approval requirements out.
If we are getting over $200m+ revenue in 2025/2026 well I don’t really need to say much more
Daybue Rollout, page-12
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |